24
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Ketoconazole
Ketoconazole 400 mg / day
BI 144807
BI144807 oral solution, intermediate dose
BI 144807
BI144807 oral solution, intermediate dose
1313.7.1 Boehringer Ingelheim Investigational Site, Biberach
Lead Sponsor
Boehringer Ingelheim
INDUSTRY